Results 141 to 150 of about 12,669 (162)
Some of the next articles are maybe not open access.
Nature Reviews Drug Discovery, 2002
Mechanisms that protect the body from a diverse array of harmful chemicals are also involved in drug metabolism, and can cause adverse drug-drug interactions. Two closely related orphan nuclear hormone receptors--the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR)--have recently emerged as transcriptional regulators of ...
Timothy M, Willson, Steven A, Kliewer
openaire +2 more sources
Mechanisms that protect the body from a diverse array of harmful chemicals are also involved in drug metabolism, and can cause adverse drug-drug interactions. Two closely related orphan nuclear hormone receptors--the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR)--have recently emerged as transcriptional regulators of ...
Timothy M, Willson, Steven A, Kliewer
openaire +2 more sources
Drug Metabolism and Disposition, 2008
The pregnane X receptor (PXR) is known as the xenosensing receptor responsible for coordinated regulation of metabolic genes in response to diverse xenobiotic challenges. In particular, the ability of the PXR to regulate CYP3A4, the enzyme capable of metabolizing more than 60% of all pharmaceuticals, defines its metabolic importance. Currently the list
Leslie M, Tompkins +2 more
openaire +2 more sources
The pregnane X receptor (PXR) is known as the xenosensing receptor responsible for coordinated regulation of metabolic genes in response to diverse xenobiotic challenges. In particular, the ability of the PXR to regulate CYP3A4, the enzyme capable of metabolizing more than 60% of all pharmaceuticals, defines its metabolic importance. Currently the list
Leslie M, Tompkins +2 more
openaire +2 more sources
PXR and CAR in energy metabolism
Trends in Endocrinology & Metabolism, 2009The nuclear receptors pregnane X receptor (PXR, or NR1I2) and constitutive androstane receptor (CAR, or NR1I3) were originally identified as xenosensors that regulate the expression of Phase I and Phase II drug-metabolizing enzymes and transporters. Recent results suggest that PXR and CAR also have important endobiotic roles in energy metabolism by ...
Taira, Wada, Jie, Gao, Wen, Xie
openaire +2 more sources
PXR mediates mifepristone-induced hepatomegaly in mice
Acta Pharmacologica Sinica, 2021Mifepristone (Mif), an effective synthetic steroidal antiprogesterone drug, is widely used for medical abortion and pregnancy prevention. Due to its anti-glucocorticoid effect, high-dose Mif is also used to treat Cushing's syndrome. Mif was reported to active pregnane X receptor (PXR) in vitro and PXR can induce hepatomegaly via activation and ...
Xin-Peng, Yao +11 more
openaire +2 more sources
CAR and PXR: Xenosensors of endocrine disrupters?
Chemico-Biological Interactions, 2005The pregnane X-receptor (PXR) and the constitutive androstane receptor (CAR) are orphan nuclear receptors activated by a variety of ligands. Currently it remains uncertain whether these receptors have a high-affinity ligand or instead function as more generalized steroid/xenobiotic sensors. Both receptors are important regulators of several steroid and
Xiomara C, Kretschmer +1 more
openaire +2 more sources
Genetic Variability of PXR in Saudi Arabians
Biochemical Genetics, 2013Polymorphisms in the PXR gene play important roles in influencing the efficacy and toxicity of a large number of endogenous and exogenous substrates. Because of ethnic specificity, several studies have been directed toward the determination of PXR polymorphisms in various populations.
Mohammed S, Al-Dosari +8 more
openaire +2 more sources
Journal of steroid biochemistry and molecular biology, 2012
Cholestatic liver disorders encompass hepatobiliary diseases of diverse etiologies characterized by the accumulation of bile acids, bilirubin and cholesterol as the result of impaired secretion of bile. Members of the nuclear receptor (NR) family of ligand-modulated transcription factors are implicated in the adaptive response to cholestasis.
Jonker, Johan W. +2 more
openaire +1 more source
Cholestatic liver disorders encompass hepatobiliary diseases of diverse etiologies characterized by the accumulation of bile acids, bilirubin and cholesterol as the result of impaired secretion of bile. Members of the nuclear receptor (NR) family of ligand-modulated transcription factors are implicated in the adaptive response to cholestasis.
Jonker, Johan W. +2 more
openaire +1 more source
Xenobiotic Receptors CAR and PXR
2010The absorption, distribution, metabolism, and excretion (ADME) of chemicals are coordinately fulfilled by drug transporters as well as phase-I and phase-II drug-metabolizing enzymes. The two so-called “xenobiotic receptors”, namely constitutive active/androstane receptor (CAR, NR1I3) and pregnane X receptor (PXR, NR1I2), are predominantly expressed in ...
Curtis Klaassen, Hong Lu
openaire +1 more source
Drug Metabolism and Disposition, 2012
Human UDP-glucuronosyltransferase (UGT) 1A1 is a critical enzyme responsible for detoxification and metabolism of endogenous and exogenous lipophilic compounds such as bilirubin. The present study shows how cyclin-dependent kinase (CDK) inhibitor roscovitine stimulated the expression of UGT1A1 in HepG2 cells.
Junko, Sugatani +6 more
openaire +2 more sources
Human UDP-glucuronosyltransferase (UGT) 1A1 is a critical enzyme responsible for detoxification and metabolism of endogenous and exogenous lipophilic compounds such as bilirubin. The present study shows how cyclin-dependent kinase (CDK) inhibitor roscovitine stimulated the expression of UGT1A1 in HepG2 cells.
Junko, Sugatani +6 more
openaire +2 more sources
2013
L’irinotecan a largement contribue aux importants progres realises ces quinze dernieres annees dans le traitement des cancers digestifs, et il occupe dorenavant une place majeure en cancerologie digestive. Developpe initialement dans le traitement du cancer colorectal avance pour lequel il est largement prescrit, l’irinotecan est egalement indique dans
openaire +1 more source
L’irinotecan a largement contribue aux importants progres realises ces quinze dernieres annees dans le traitement des cancers digestifs, et il occupe dorenavant une place majeure en cancerologie digestive. Developpe initialement dans le traitement du cancer colorectal avance pour lequel il est largement prescrit, l’irinotecan est egalement indique dans
openaire +1 more source

